HOOKIPA PHARMA INC
COM · CUSIP 43906K100
1
institutional holders
+0 vs Q1 2025
498.6k
shares reported held*
$625.8kreported value*
0 new
0 added
0 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.25.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 54 |
| Q4 2022 | 55 |
| Q1 2023 | 46 |
| Q2 2023 | 54 |
| Q3 2023 | 46 |
| Q4 2023 | 42 |
| Q1 2024 | 48 |
| Q2 2024 | 40 |
| Q3 2024 | 1 |
| Q4 2024 | 1 |
| Q1 2025 | 1 |
| Q2 2025 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 13 | 27 |
| Q4 2023 | 15 | 22 |
| Q1 2024 | 20 | 9 |
| Q2 2024 | 22 | 21 |
| Q3 2024 | 0 | 39 |
| Q4 2024 | 0 | 1 |
| Q1 2025 | 0 | 0 |
| Q2 2025 | 0 | 0 |
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLC 0.44% of their portfolio | 498.6k $625.8k | Unchanged |